Pharma & Healthcare
Global Adult Preventable Vaccines Market Research Report 2026
- Feb 03, 26
- ID: 695213
- Pages: 123
- Figures: 119
- Views: 4
This report delivers a comprehensive overview of the global Adult Preventable Vaccines market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Adult Preventable Vaccines. The Adult Preventable Vaccines market size, estimates, and forecasts are provided in terms of sales volume (K Dose) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Adult Preventable Vaccines market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Adult Preventable Vaccines manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Pfizer Inc.
Merck & Co., Inc.
GlaxoSmithKline plc (GSK)
Sanofi Pasteur
Moderna, Inc.
Serum Institute of India Pvt.
Bharat Biotech International
CSL Limited (Seqirus)
Emergent BioSolutions Inc.
Daiichi Sankyo Company
Novavax, Inc.
Sinovac Biotech
Sinopharm Group Co.,
Johnson & Johnson (Janssen)
AstraZeneca plc
Segment by Type
Inactivated Vaccines
Subunit Vaccines
Mrna Vaccines
Viral Vector Vaccines
Peptide Vaccines
by Application
Prevent Influenza
Prevent Pneumococcal Infection
Prevent Hepatitis B
Prevent Herpes Zoster
Prevent Human Papillomavirus (Hpv)
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Adult Preventable Vaccines manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Adult Preventable Vaccines sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Adult Preventable Vaccines market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Adult Preventable Vaccines manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Pfizer Inc.
Merck & Co., Inc.
GlaxoSmithKline plc (GSK)
Sanofi Pasteur
Moderna, Inc.
Serum Institute of India Pvt.
Bharat Biotech International
CSL Limited (Seqirus)
Emergent BioSolutions Inc.
Daiichi Sankyo Company
Novavax, Inc.
Sinovac Biotech
Sinopharm Group Co.,
Johnson & Johnson (Janssen)
AstraZeneca plc
Segment by Type
Inactivated Vaccines
Subunit Vaccines
Mrna Vaccines
Viral Vector Vaccines
Peptide Vaccines
by Application
Prevent Influenza
Prevent Pneumococcal Infection
Prevent Hepatitis B
Prevent Herpes Zoster
Prevent Human Papillomavirus (Hpv)
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Adult Preventable Vaccines manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Adult Preventable Vaccines sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Adult Preventable Vaccines Market Overview
1.1 Product Definition
1.2 Adult Preventable Vaccines by Type
1.2.1 Global Adult Preventable Vaccines Market Value by Type: 2025 vs 2032
1.2.2 Inactivated Vaccines
1.2.3 Subunit Vaccines
1.2.4 Mrna Vaccines
1.2.5 Viral Vector Vaccines
1.2.6 Peptide Vaccines
1.3 Adult Preventable Vaccines by Application
1.3.1 Global Adult Preventable Vaccines Market Value by Application: 2025 vs 2032
1.3.2 Prevent Influenza
1.3.3 Prevent Pneumococcal Infection
1.3.4 Prevent Hepatitis B
1.3.5 Prevent Herpes Zoster
1.3.6 Prevent Human Papillomavirus (Hpv)
1.3.7 Other
1.4 Global Adult Preventable Vaccines Market Size Estimates and Forecasts
1.4.1 Global Adult Preventable Vaccines Revenue 2021–2032
1.4.2 Global Adult Preventable Vaccines Sales 2021–2032
1.4.3 Global Adult Preventable Vaccines Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Adult Preventable Vaccines Market Competition by Manufacturers
2.1 Global Adult Preventable Vaccines Sales Market Share by Manufacturers (2021–2026)
2.2 Global Adult Preventable Vaccines Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Adult Preventable Vaccines Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Adult Preventable Vaccines, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Adult Preventable Vaccines, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Adult Preventable Vaccines, Product Types and Applications
2.7 Global Key Manufacturers of Adult Preventable Vaccines, Date of Entry into the Industry
2.8 Global Adult Preventable Vaccines Market Competitive Situation and Trends
2.8.1 Global Adult Preventable Vaccines Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Adult Preventable Vaccines Players Market Share by Revenue
2.8.3 Global Adult Preventable Vaccines Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Adult Preventable Vaccines Market Scenario by Region
3.1 Global Adult Preventable Vaccines Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Adult Preventable Vaccines Sales by Region: 2021–2032
3.2.1 Global Adult Preventable Vaccines Sales by Region: 2021–2026
3.2.2 Global Adult Preventable Vaccines Sales by Region: 2027–2032
3.3 Global Adult Preventable Vaccines Revenue by Region: 2021–2032
3.3.1 Global Adult Preventable Vaccines Revenue by Region: 2021–2026
3.3.2 Global Adult Preventable Vaccines Revenue by Region: 2027–2032
3.4 North America Adult Preventable Vaccines Market Facts & Figures by Country
3.4.1 North America Adult Preventable Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Adult Preventable Vaccines Sales by Country (2021–2032)
3.4.3 North America Adult Preventable Vaccines Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Adult Preventable Vaccines Market Facts & Figures by Country
3.5.1 Europe Adult Preventable Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Adult Preventable Vaccines Sales by Country (2021–2032)
3.5.3 Europe Adult Preventable Vaccines Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Adult Preventable Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Adult Preventable Vaccines Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Adult Preventable Vaccines Sales by Region (2021–2032)
3.6.3 Asia Pacific Adult Preventable Vaccines Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Adult Preventable Vaccines Market Facts & Figures by Country
3.7.1 Latin America Adult Preventable Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Adult Preventable Vaccines Sales by Country (2021–2032)
3.7.3 Latin America Adult Preventable Vaccines Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Adult Preventable Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Adult Preventable Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Adult Preventable Vaccines Sales by Country (2021–2032)
3.8.3 Middle East and Africa Adult Preventable Vaccines Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Adult Preventable Vaccines Sales by Type (2021–2032)
4.1.1 Global Adult Preventable Vaccines Sales by Type (2021–2026)
4.1.2 Global Adult Preventable Vaccines Sales by Type (2027–2032)
4.1.3 Global Adult Preventable Vaccines Sales Market Share by Type (2021–2032)
4.2 Global Adult Preventable Vaccines Revenue by Type (2021–2032)
4.2.1 Global Adult Preventable Vaccines Revenue by Type (2021–2026)
4.2.2 Global Adult Preventable Vaccines Revenue by Type (2027–2032)
4.2.3 Global Adult Preventable Vaccines Revenue Market Share by Type (2021–2032)
4.3 Global Adult Preventable Vaccines Price by Type (2021–2032)
5 Segment by Application
5.1 Global Adult Preventable Vaccines Sales by Application (2021–2032)
5.1.1 Global Adult Preventable Vaccines Sales by Application (2021–2026)
5.1.2 Global Adult Preventable Vaccines Sales by Application (2027–2032)
5.1.3 Global Adult Preventable Vaccines Sales Market Share by Application (2021–2032)
5.2 Global Adult Preventable Vaccines Revenue by Application (2021–2032)
5.2.1 Global Adult Preventable Vaccines Revenue by Application (2021–2026)
5.2.2 Global Adult Preventable Vaccines Revenue by Application (2027–2032)
5.2.3 Global Adult Preventable Vaccines Revenue Market Share by Application (2021–2032)
5.3 Global Adult Preventable Vaccines Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Pfizer Inc.
6.1.1 Pfizer Inc. Company Information
6.1.2 Pfizer Inc. Description and Business Overview
6.1.3 Pfizer Inc. Adult Preventable Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Pfizer Inc. Adult Preventable Vaccines Product Portfolio
6.1.5 Pfizer Inc. Recent Developments/Updates
6.2 Merck & Co., Inc.
6.2.1 Merck & Co., Inc. Company Information
6.2.2 Merck & Co., Inc. Description and Business Overview
6.2.3 Merck & Co., Inc. Adult Preventable Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Merck & Co., Inc. Adult Preventable Vaccines Product Portfolio
6.2.5 Merck & Co., Inc. Recent Developments/Updates
6.3 GlaxoSmithKline plc (GSK)
6.3.1 GlaxoSmithKline plc (GSK) Company Information
6.3.2 GlaxoSmithKline plc (GSK) Description and Business Overview
6.3.3 GlaxoSmithKline plc (GSK) Adult Preventable Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 GlaxoSmithKline plc (GSK) Adult Preventable Vaccines Product Portfolio
6.3.5 GlaxoSmithKline plc (GSK) Recent Developments/Updates
6.4 Sanofi Pasteur
6.4.1 Sanofi Pasteur Company Information
6.4.2 Sanofi Pasteur Description and Business Overview
6.4.3 Sanofi Pasteur Adult Preventable Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Sanofi Pasteur Adult Preventable Vaccines Product Portfolio
6.4.5 Sanofi Pasteur Recent Developments/Updates
6.5 Moderna, Inc.
6.5.1 Moderna, Inc. Company Information
6.5.2 Moderna, Inc. Description and Business Overview
6.5.3 Moderna, Inc. Adult Preventable Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Moderna, Inc. Adult Preventable Vaccines Product Portfolio
6.5.5 Moderna, Inc. Recent Developments/Updates
6.6 Serum Institute of India Pvt.
6.6.1 Serum Institute of India Pvt. Company Information
6.6.2 Serum Institute of India Pvt. Description and Business Overview
6.6.3 Serum Institute of India Pvt. Adult Preventable Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Serum Institute of India Pvt. Adult Preventable Vaccines Product Portfolio
6.6.5 Serum Institute of India Pvt. Recent Developments/Updates
6.7 Bharat Biotech International
6.7.1 Bharat Biotech International Company Information
6.7.2 Bharat Biotech International Description and Business Overview
6.7.3 Bharat Biotech International Adult Preventable Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Bharat Biotech International Adult Preventable Vaccines Product Portfolio
6.7.5 Bharat Biotech International Recent Developments/Updates
6.8 CSL Limited (Seqirus)
6.8.1 CSL Limited (Seqirus) Company Information
6.8.2 CSL Limited (Seqirus) Description and Business Overview
6.8.3 CSL Limited (Seqirus) Adult Preventable Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 CSL Limited (Seqirus) Adult Preventable Vaccines Product Portfolio
6.8.5 CSL Limited (Seqirus) Recent Developments/Updates
6.9 Emergent BioSolutions Inc.
6.9.1 Emergent BioSolutions Inc. Company Information
6.9.2 Emergent BioSolutions Inc. Description and Business Overview
6.9.3 Emergent BioSolutions Inc. Adult Preventable Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Emergent BioSolutions Inc. Adult Preventable Vaccines Product Portfolio
6.9.5 Emergent BioSolutions Inc. Recent Developments/Updates
6.10 Daiichi Sankyo Company
6.10.1 Daiichi Sankyo Company Company Information
6.10.2 Daiichi Sankyo Company Description and Business Overview
6.10.3 Daiichi Sankyo Company Adult Preventable Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Daiichi Sankyo Company Adult Preventable Vaccines Product Portfolio
6.10.5 Daiichi Sankyo Company Recent Developments/Updates
6.11 Novavax, Inc.
6.11.1 Novavax, Inc. Company Information
6.11.2 Novavax, Inc. Description and Business Overview
6.11.3 Novavax, Inc. Adult Preventable Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Novavax, Inc. Adult Preventable Vaccines Product Portfolio
6.11.5 Novavax, Inc. Recent Developments/Updates
6.12 Sinovac Biotech
6.12.1 Sinovac Biotech Company Information
6.12.2 Sinovac Biotech Description and Business Overview
6.12.3 Sinovac Biotech Adult Preventable Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Sinovac Biotech Adult Preventable Vaccines Product Portfolio
6.12.5 Sinovac Biotech Recent Developments/Updates
6.13 Sinopharm Group Co.,
6.13.1 Sinopharm Group Co., Company Information
6.13.2 Sinopharm Group Co., Description and Business Overview
6.13.3 Sinopharm Group Co., Adult Preventable Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Sinopharm Group Co., Adult Preventable Vaccines Product Portfolio
6.13.5 Sinopharm Group Co., Recent Developments/Updates
6.14 Johnson & Johnson (Janssen)
6.14.1 Johnson & Johnson (Janssen) Company Information
6.14.2 Johnson & Johnson (Janssen) Description and Business Overview
6.14.3 Johnson & Johnson (Janssen) Adult Preventable Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Johnson & Johnson (Janssen) Adult Preventable Vaccines Product Portfolio
6.14.5 Johnson & Johnson (Janssen) Recent Developments/Updates
6.15 AstraZeneca plc
6.15.1 AstraZeneca plc Company Information
6.15.2 AstraZeneca plc Description and Business Overview
6.15.3 AstraZeneca plc Adult Preventable Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 AstraZeneca plc Adult Preventable Vaccines Product Portfolio
6.15.5 AstraZeneca plc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Adult Preventable Vaccines Industry Chain Analysis
7.2 Adult Preventable Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Adult Preventable Vaccines Production Mode & Process Analysis
7.4 Adult Preventable Vaccines Sales and Marketing
7.4.1 Adult Preventable Vaccines Sales Channels
7.4.2 Adult Preventable Vaccines Distributors
7.5 Adult Preventable Vaccines Customer Analysis
8 Adult Preventable Vaccines Market Dynamics
8.1 Adult Preventable Vaccines Industry Trends
8.2 Adult Preventable Vaccines Market Drivers
8.3 Adult Preventable Vaccines Market Challenges
8.4 Adult Preventable Vaccines Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Adult Preventable Vaccines by Type
1.2.1 Global Adult Preventable Vaccines Market Value by Type: 2025 vs 2032
1.2.2 Inactivated Vaccines
1.2.3 Subunit Vaccines
1.2.4 Mrna Vaccines
1.2.5 Viral Vector Vaccines
1.2.6 Peptide Vaccines
1.3 Adult Preventable Vaccines by Application
1.3.1 Global Adult Preventable Vaccines Market Value by Application: 2025 vs 2032
1.3.2 Prevent Influenza
1.3.3 Prevent Pneumococcal Infection
1.3.4 Prevent Hepatitis B
1.3.5 Prevent Herpes Zoster
1.3.6 Prevent Human Papillomavirus (Hpv)
1.3.7 Other
1.4 Global Adult Preventable Vaccines Market Size Estimates and Forecasts
1.4.1 Global Adult Preventable Vaccines Revenue 2021–2032
1.4.2 Global Adult Preventable Vaccines Sales 2021–2032
1.4.3 Global Adult Preventable Vaccines Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Adult Preventable Vaccines Market Competition by Manufacturers
2.1 Global Adult Preventable Vaccines Sales Market Share by Manufacturers (2021–2026)
2.2 Global Adult Preventable Vaccines Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Adult Preventable Vaccines Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Adult Preventable Vaccines, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Adult Preventable Vaccines, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Adult Preventable Vaccines, Product Types and Applications
2.7 Global Key Manufacturers of Adult Preventable Vaccines, Date of Entry into the Industry
2.8 Global Adult Preventable Vaccines Market Competitive Situation and Trends
2.8.1 Global Adult Preventable Vaccines Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Adult Preventable Vaccines Players Market Share by Revenue
2.8.3 Global Adult Preventable Vaccines Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Adult Preventable Vaccines Market Scenario by Region
3.1 Global Adult Preventable Vaccines Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Adult Preventable Vaccines Sales by Region: 2021–2032
3.2.1 Global Adult Preventable Vaccines Sales by Region: 2021–2026
3.2.2 Global Adult Preventable Vaccines Sales by Region: 2027–2032
3.3 Global Adult Preventable Vaccines Revenue by Region: 2021–2032
3.3.1 Global Adult Preventable Vaccines Revenue by Region: 2021–2026
3.3.2 Global Adult Preventable Vaccines Revenue by Region: 2027–2032
3.4 North America Adult Preventable Vaccines Market Facts & Figures by Country
3.4.1 North America Adult Preventable Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Adult Preventable Vaccines Sales by Country (2021–2032)
3.4.3 North America Adult Preventable Vaccines Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Adult Preventable Vaccines Market Facts & Figures by Country
3.5.1 Europe Adult Preventable Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Adult Preventable Vaccines Sales by Country (2021–2032)
3.5.3 Europe Adult Preventable Vaccines Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Adult Preventable Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Adult Preventable Vaccines Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Adult Preventable Vaccines Sales by Region (2021–2032)
3.6.3 Asia Pacific Adult Preventable Vaccines Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Adult Preventable Vaccines Market Facts & Figures by Country
3.7.1 Latin America Adult Preventable Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Adult Preventable Vaccines Sales by Country (2021–2032)
3.7.3 Latin America Adult Preventable Vaccines Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Adult Preventable Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Adult Preventable Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Adult Preventable Vaccines Sales by Country (2021–2032)
3.8.3 Middle East and Africa Adult Preventable Vaccines Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Adult Preventable Vaccines Sales by Type (2021–2032)
4.1.1 Global Adult Preventable Vaccines Sales by Type (2021–2026)
4.1.2 Global Adult Preventable Vaccines Sales by Type (2027–2032)
4.1.3 Global Adult Preventable Vaccines Sales Market Share by Type (2021–2032)
4.2 Global Adult Preventable Vaccines Revenue by Type (2021–2032)
4.2.1 Global Adult Preventable Vaccines Revenue by Type (2021–2026)
4.2.2 Global Adult Preventable Vaccines Revenue by Type (2027–2032)
4.2.3 Global Adult Preventable Vaccines Revenue Market Share by Type (2021–2032)
4.3 Global Adult Preventable Vaccines Price by Type (2021–2032)
5 Segment by Application
5.1 Global Adult Preventable Vaccines Sales by Application (2021–2032)
5.1.1 Global Adult Preventable Vaccines Sales by Application (2021–2026)
5.1.2 Global Adult Preventable Vaccines Sales by Application (2027–2032)
5.1.3 Global Adult Preventable Vaccines Sales Market Share by Application (2021–2032)
5.2 Global Adult Preventable Vaccines Revenue by Application (2021–2032)
5.2.1 Global Adult Preventable Vaccines Revenue by Application (2021–2026)
5.2.2 Global Adult Preventable Vaccines Revenue by Application (2027–2032)
5.2.3 Global Adult Preventable Vaccines Revenue Market Share by Application (2021–2032)
5.3 Global Adult Preventable Vaccines Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Pfizer Inc.
6.1.1 Pfizer Inc. Company Information
6.1.2 Pfizer Inc. Description and Business Overview
6.1.3 Pfizer Inc. Adult Preventable Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Pfizer Inc. Adult Preventable Vaccines Product Portfolio
6.1.5 Pfizer Inc. Recent Developments/Updates
6.2 Merck & Co., Inc.
6.2.1 Merck & Co., Inc. Company Information
6.2.2 Merck & Co., Inc. Description and Business Overview
6.2.3 Merck & Co., Inc. Adult Preventable Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Merck & Co., Inc. Adult Preventable Vaccines Product Portfolio
6.2.5 Merck & Co., Inc. Recent Developments/Updates
6.3 GlaxoSmithKline plc (GSK)
6.3.1 GlaxoSmithKline plc (GSK) Company Information
6.3.2 GlaxoSmithKline plc (GSK) Description and Business Overview
6.3.3 GlaxoSmithKline plc (GSK) Adult Preventable Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 GlaxoSmithKline plc (GSK) Adult Preventable Vaccines Product Portfolio
6.3.5 GlaxoSmithKline plc (GSK) Recent Developments/Updates
6.4 Sanofi Pasteur
6.4.1 Sanofi Pasteur Company Information
6.4.2 Sanofi Pasteur Description and Business Overview
6.4.3 Sanofi Pasteur Adult Preventable Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Sanofi Pasteur Adult Preventable Vaccines Product Portfolio
6.4.5 Sanofi Pasteur Recent Developments/Updates
6.5 Moderna, Inc.
6.5.1 Moderna, Inc. Company Information
6.5.2 Moderna, Inc. Description and Business Overview
6.5.3 Moderna, Inc. Adult Preventable Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Moderna, Inc. Adult Preventable Vaccines Product Portfolio
6.5.5 Moderna, Inc. Recent Developments/Updates
6.6 Serum Institute of India Pvt.
6.6.1 Serum Institute of India Pvt. Company Information
6.6.2 Serum Institute of India Pvt. Description and Business Overview
6.6.3 Serum Institute of India Pvt. Adult Preventable Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Serum Institute of India Pvt. Adult Preventable Vaccines Product Portfolio
6.6.5 Serum Institute of India Pvt. Recent Developments/Updates
6.7 Bharat Biotech International
6.7.1 Bharat Biotech International Company Information
6.7.2 Bharat Biotech International Description and Business Overview
6.7.3 Bharat Biotech International Adult Preventable Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Bharat Biotech International Adult Preventable Vaccines Product Portfolio
6.7.5 Bharat Biotech International Recent Developments/Updates
6.8 CSL Limited (Seqirus)
6.8.1 CSL Limited (Seqirus) Company Information
6.8.2 CSL Limited (Seqirus) Description and Business Overview
6.8.3 CSL Limited (Seqirus) Adult Preventable Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 CSL Limited (Seqirus) Adult Preventable Vaccines Product Portfolio
6.8.5 CSL Limited (Seqirus) Recent Developments/Updates
6.9 Emergent BioSolutions Inc.
6.9.1 Emergent BioSolutions Inc. Company Information
6.9.2 Emergent BioSolutions Inc. Description and Business Overview
6.9.3 Emergent BioSolutions Inc. Adult Preventable Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Emergent BioSolutions Inc. Adult Preventable Vaccines Product Portfolio
6.9.5 Emergent BioSolutions Inc. Recent Developments/Updates
6.10 Daiichi Sankyo Company
6.10.1 Daiichi Sankyo Company Company Information
6.10.2 Daiichi Sankyo Company Description and Business Overview
6.10.3 Daiichi Sankyo Company Adult Preventable Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Daiichi Sankyo Company Adult Preventable Vaccines Product Portfolio
6.10.5 Daiichi Sankyo Company Recent Developments/Updates
6.11 Novavax, Inc.
6.11.1 Novavax, Inc. Company Information
6.11.2 Novavax, Inc. Description and Business Overview
6.11.3 Novavax, Inc. Adult Preventable Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Novavax, Inc. Adult Preventable Vaccines Product Portfolio
6.11.5 Novavax, Inc. Recent Developments/Updates
6.12 Sinovac Biotech
6.12.1 Sinovac Biotech Company Information
6.12.2 Sinovac Biotech Description and Business Overview
6.12.3 Sinovac Biotech Adult Preventable Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Sinovac Biotech Adult Preventable Vaccines Product Portfolio
6.12.5 Sinovac Biotech Recent Developments/Updates
6.13 Sinopharm Group Co.,
6.13.1 Sinopharm Group Co., Company Information
6.13.2 Sinopharm Group Co., Description and Business Overview
6.13.3 Sinopharm Group Co., Adult Preventable Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Sinopharm Group Co., Adult Preventable Vaccines Product Portfolio
6.13.5 Sinopharm Group Co., Recent Developments/Updates
6.14 Johnson & Johnson (Janssen)
6.14.1 Johnson & Johnson (Janssen) Company Information
6.14.2 Johnson & Johnson (Janssen) Description and Business Overview
6.14.3 Johnson & Johnson (Janssen) Adult Preventable Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Johnson & Johnson (Janssen) Adult Preventable Vaccines Product Portfolio
6.14.5 Johnson & Johnson (Janssen) Recent Developments/Updates
6.15 AstraZeneca plc
6.15.1 AstraZeneca plc Company Information
6.15.2 AstraZeneca plc Description and Business Overview
6.15.3 AstraZeneca plc Adult Preventable Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 AstraZeneca plc Adult Preventable Vaccines Product Portfolio
6.15.5 AstraZeneca plc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Adult Preventable Vaccines Industry Chain Analysis
7.2 Adult Preventable Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Adult Preventable Vaccines Production Mode & Process Analysis
7.4 Adult Preventable Vaccines Sales and Marketing
7.4.1 Adult Preventable Vaccines Sales Channels
7.4.2 Adult Preventable Vaccines Distributors
7.5 Adult Preventable Vaccines Customer Analysis
8 Adult Preventable Vaccines Market Dynamics
8.1 Adult Preventable Vaccines Industry Trends
8.2 Adult Preventable Vaccines Market Drivers
8.3 Adult Preventable Vaccines Market Challenges
8.4 Adult Preventable Vaccines Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Adult Preventable Vaccines Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Adult Preventable Vaccines Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Adult Preventable Vaccines Market Competitive Situation by Manufacturers in 2025
Table 4. Global Adult Preventable Vaccines Sales (K Dose) of Key Manufacturers (2021–2026)
Table 5. Global Adult Preventable Vaccines Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Adult Preventable Vaccines Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Adult Preventable Vaccines Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Adult Preventable Vaccines Average Price (US$/Dose) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Adult Preventable Vaccines, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Adult Preventable Vaccines, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Adult Preventable Vaccines, Product Types and Applications
Table 12. Global Key Manufacturers of Adult Preventable Vaccines, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Adult Preventable Vaccines Companies by Tier (Tier 1, Tier 2, Tier 3), based on Adult Preventable Vaccines Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Adult Preventable Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Adult Preventable Vaccines Sales by Region (K Dose), 2021–2026
Table 18. Global Adult Preventable Vaccines Sales Market Share by Region (2021–2026)
Table 19. Global Adult Preventable Vaccines Sales by Region (K Dose), 2027–2032
Table 20. Global Adult Preventable Vaccines Sales Market Share by Region (2027–2032)
Table 21. Global Adult Preventable Vaccines Revenue by Region (US$ Million), 2021–2026
Table 22. Global Adult Preventable Vaccines Revenue Market Share by Region (2021–2026)
Table 23. Global Adult Preventable Vaccines Revenue by Region (US$ Million), 2027–2032
Table 24. Global Adult Preventable Vaccines Revenue Market Share by Region (2027–2032)
Table 25. North America Adult Preventable Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Adult Preventable Vaccines Sales by Country (K Dose), 2021–2026
Table 27. North America Adult Preventable Vaccines Sales by Country (K Dose), 2027–2032
Table 28. North America Adult Preventable Vaccines Revenue by Country (US$ Million), 2021–2026
Table 29. North America Adult Preventable Vaccines Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Adult Preventable Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Adult Preventable Vaccines Sales by Country (K Dose), 2021–2026
Table 32. Europe Adult Preventable Vaccines Sales by Country (K Dose), 2027–2032
Table 33. Europe Adult Preventable Vaccines Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Adult Preventable Vaccines Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Adult Preventable Vaccines Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Adult Preventable Vaccines Sales by Region (K Dose), 2021–2026
Table 37. Asia Pacific Adult Preventable Vaccines Sales by Region (K Dose), 2027–2032
Table 38. Asia Pacific Adult Preventable Vaccines Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Adult Preventable Vaccines Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Adult Preventable Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Adult Preventable Vaccines Sales by Country (K Dose), 2021–2026
Table 42. Latin America Adult Preventable Vaccines Sales by Country (K Dose), 2027–2032
Table 43. Latin America Adult Preventable Vaccines Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Adult Preventable Vaccines Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Adult Preventable Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Adult Preventable Vaccines Sales by Country (K Dose), 2021–2026
Table 47. Middle East and Africa Adult Preventable Vaccines Sales by Country (K Dose), 2027–2032
Table 48. Middle East and Africa Adult Preventable Vaccines Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Adult Preventable Vaccines Revenue by Country (US$ Million), 2027–2032
Table 50. Global Adult Preventable Vaccines Sales (K Dose) by Type (2021–2026)
Table 51. Global Adult Preventable Vaccines Sales (K Dose) by Type (2027–2032)
Table 52. Global Adult Preventable Vaccines Sales Market Share by Type (2021–2026)
Table 53. Global Adult Preventable Vaccines Sales Market Share by Type (2027–2032)
Table 54. Global Adult Preventable Vaccines Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Adult Preventable Vaccines Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Adult Preventable Vaccines Revenue Market Share by Type (2021–2026)
Table 57. Global Adult Preventable Vaccines Revenue Market Share by Type (2027–2032)
Table 58. Global Adult Preventable Vaccines Price (US$/Dose) by Type (2021–2026)
Table 59. Global Adult Preventable Vaccines Price (US$/Dose) by Type (2027–2032)
Table 60. Global Adult Preventable Vaccines Sales (K Dose) by Application (2021–2026)
Table 61. Global Adult Preventable Vaccines Sales (K Dose) by Application (2027–2032)
Table 62. Global Adult Preventable Vaccines Sales Market Share by Application (2021–2026)
Table 63. Global Adult Preventable Vaccines Sales Market Share by Application (2027–2032)
Table 64. Global Adult Preventable Vaccines Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Adult Preventable Vaccines Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Adult Preventable Vaccines Revenue Market Share by Application (2021–2026)
Table 67. Global Adult Preventable Vaccines Revenue Market Share by Application (2027–2032)
Table 68. Global Adult Preventable Vaccines Price (US$/Dose) by Application (2021–2026)
Table 69. Global Adult Preventable Vaccines Price (US$/Dose) by Application (2027–2032)
Table 70. Pfizer Inc. Company Information
Table 71. Pfizer Inc. Description and Business Overview
Table 72. Pfizer Inc. Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 73. Pfizer Inc. Adult Preventable Vaccines Product
Table 74. Pfizer Inc. Recent Developments/Updates
Table 75. Merck & Co., Inc. Company Information
Table 76. Merck & Co., Inc. Description and Business Overview
Table 77. Merck & Co., Inc. Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 78. Merck & Co., Inc. Adult Preventable Vaccines Product
Table 79. Merck & Co., Inc. Recent Developments/Updates
Table 80. GlaxoSmithKline plc (GSK) Company Information
Table 81. GlaxoSmithKline plc (GSK) Description and Business Overview
Table 82. GlaxoSmithKline plc (GSK) Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 83. GlaxoSmithKline plc (GSK) Adult Preventable Vaccines Product
Table 84. GlaxoSmithKline plc (GSK) Recent Developments/Updates
Table 85. Sanofi Pasteur Company Information
Table 86. Sanofi Pasteur Description and Business Overview
Table 87. Sanofi Pasteur Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 88. Sanofi Pasteur Adult Preventable Vaccines Product
Table 89. Sanofi Pasteur Recent Developments/Updates
Table 90. Moderna, Inc. Company Information
Table 91. Moderna, Inc. Description and Business Overview
Table 92. Moderna, Inc. Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 93. Moderna, Inc. Adult Preventable Vaccines Product
Table 94. Moderna, Inc. Recent Developments/Updates
Table 95. Serum Institute of India Pvt. Company Information
Table 96. Serum Institute of India Pvt. Description and Business Overview
Table 97. Serum Institute of India Pvt. Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 98. Serum Institute of India Pvt. Adult Preventable Vaccines Product
Table 99. Serum Institute of India Pvt. Recent Developments/Updates
Table 100. Bharat Biotech International Company Information
Table 101. Bharat Biotech International Description and Business Overview
Table 102. Bharat Biotech International Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 103. Bharat Biotech International Adult Preventable Vaccines Product
Table 104. Bharat Biotech International Recent Developments/Updates
Table 105. CSL Limited (Seqirus) Company Information
Table 106. CSL Limited (Seqirus) Description and Business Overview
Table 107. CSL Limited (Seqirus) Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 108. CSL Limited (Seqirus) Adult Preventable Vaccines Product
Table 109. CSL Limited (Seqirus) Recent Developments/Updates
Table 110. Emergent BioSolutions Inc. Company Information
Table 111. Emergent BioSolutions Inc. Description and Business Overview
Table 112. Emergent BioSolutions Inc. Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 113. Emergent BioSolutions Inc. Adult Preventable Vaccines Product
Table 114. Emergent BioSolutions Inc. Recent Developments/Updates
Table 115. Daiichi Sankyo Company Company Information
Table 116. Daiichi Sankyo Company Description and Business Overview
Table 117. Daiichi Sankyo Company Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 118. Daiichi Sankyo Company Adult Preventable Vaccines Product
Table 119. Daiichi Sankyo Company Recent Developments/Updates
Table 120. Novavax, Inc. Company Information
Table 121. Novavax, Inc. Description and Business Overview
Table 122. Novavax, Inc. Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 123. Novavax, Inc. Adult Preventable Vaccines Product
Table 124. Novavax, Inc. Recent Developments/Updates
Table 125. Sinovac Biotech Company Information
Table 126. Sinovac Biotech Description and Business Overview
Table 127. Sinovac Biotech Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 128. Sinovac Biotech Adult Preventable Vaccines Product
Table 129. Sinovac Biotech Recent Developments/Updates
Table 130. Sinopharm Group Co., Company Information
Table 131. Sinopharm Group Co., Description and Business Overview
Table 132. Sinopharm Group Co., Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 133. Sinopharm Group Co., Adult Preventable Vaccines Product
Table 134. Sinopharm Group Co., Recent Developments/Updates
Table 135. Johnson & Johnson (Janssen) Company Information
Table 136. Johnson & Johnson (Janssen) Description and Business Overview
Table 137. Johnson & Johnson (Janssen) Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 138. Johnson & Johnson (Janssen) Adult Preventable Vaccines Product
Table 139. Johnson & Johnson (Janssen) Recent Developments/Updates
Table 140. AstraZeneca plc Company Information
Table 141. AstraZeneca plc Description and Business Overview
Table 142. AstraZeneca plc Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 143. AstraZeneca plc Adult Preventable Vaccines Product
Table 144. AstraZeneca plc Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Adult Preventable Vaccines Distributors List
Table 148. Adult Preventable Vaccines Customers List
Table 149. Adult Preventable Vaccines Market Trends
Table 150. Adult Preventable Vaccines Market Drivers
Table 151. Adult Preventable Vaccines Market Challenges
Table 152. Adult Preventable Vaccines Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Adult Preventable Vaccines
Figure 2. Global Adult Preventable Vaccines Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Adult Preventable Vaccines Market Share by Type: 2025 & 2032
Figure 4. Inactivated Vaccines Product Picture
Figure 5. Subunit Vaccines Product Picture
Figure 6. Mrna Vaccines Product Picture
Figure 7. Viral Vector Vaccines Product Picture
Figure 8. Peptide Vaccines Product Picture
Figure 9. Global Adult Preventable Vaccines Market Value by Application (US$ Million), 2021–2032
Figure 10. Global Adult Preventable Vaccines Market Share by Application: 2025 & 2032
Figure 11. Prevent Influenza
Figure 12. Prevent Pneumococcal Infection
Figure 13. Prevent Hepatitis B
Figure 14. Prevent Herpes Zoster
Figure 15. Prevent Human Papillomavirus (Hpv)
Figure 16. Other
Figure 17. Global Adult Preventable Vaccines Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 18. Global Adult Preventable Vaccines Market Size (US$ Million), 2021–2032
Figure 19. Global Adult Preventable Vaccines Sales (K Dose), 2021–2032
Figure 20. Global Adult Preventable Vaccines Average Price (US$/Dose), 2021–2032
Figure 21. Adult Preventable Vaccines Report Years Considered
Figure 22. Adult Preventable Vaccines Sales Share by Manufacturers in 2025
Figure 23. Global Adult Preventable Vaccines Revenue Share by Manufacturers in 2025
Figure 24. Top 5 and Top 10 Global Adult Preventable Vaccines Players: Market Share by Revenue in Adult Preventable Vaccines in 2025
Figure 25. Adult Preventable Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 26. Global Adult Preventable Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 27. North America Adult Preventable Vaccines Sales Market Share by Country (2021–2032)
Figure 28. North America Adult Preventable Vaccines Revenue Market Share by Country (2021–2032)
Figure 29. United States Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Canada Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Europe Adult Preventable Vaccines Sales Market Share by Country (2021–2032)
Figure 32. Europe Adult Preventable Vaccines Revenue Market Share by Country (2021–2032)
Figure 33. Germany Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. France Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. U.K. Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Italy Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Russia Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Asia Pacific Adult Preventable Vaccines Sales Market Share by Region (2021–2032)
Figure 39. Asia Pacific Adult Preventable Vaccines Revenue Market Share by Region (2021–2032)
Figure 40. China Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Japan Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. South Korea Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. India Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Australia Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. China Taiwan Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Southeast Asia Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Latin America Adult Preventable Vaccines Sales Market Share by Country (2021–2032)
Figure 48. Latin America Adult Preventable Vaccines Revenue Market Share by Country (2021–2032)
Figure 49. Mexico Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Brazil Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Argentina Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Colombia Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Middle East and Africa Adult Preventable Vaccines Sales Market Share by Country (2021–2032)
Figure 54. Middle East and Africa Adult Preventable Vaccines Revenue Market Share by Country (2021–2032)
Figure 55. Turkey Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Saudi Arabia Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. UAE Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Global Sales Market Share of Adult Preventable Vaccines by Type (2021–2032)
Figure 59. Global Revenue Market Share of Adult Preventable Vaccines by Type (2021–2032)
Figure 60. Global Adult Preventable Vaccines Price (US$/Dose) by Type (2021–2032)
Figure 61. Global Sales Market Share of Adult Preventable Vaccines by Application (2021–2032)
Figure 62. Global Revenue Market Share of Adult Preventable Vaccines by Application (2021–2032)
Figure 63. Global Adult Preventable Vaccines Price (US$/Dose) by Application (2021–2032)
Figure 64. Adult Preventable Vaccines Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Table 1. Global Adult Preventable Vaccines Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Adult Preventable Vaccines Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Adult Preventable Vaccines Market Competitive Situation by Manufacturers in 2025
Table 4. Global Adult Preventable Vaccines Sales (K Dose) of Key Manufacturers (2021–2026)
Table 5. Global Adult Preventable Vaccines Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Adult Preventable Vaccines Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Adult Preventable Vaccines Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Adult Preventable Vaccines Average Price (US$/Dose) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Adult Preventable Vaccines, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Adult Preventable Vaccines, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Adult Preventable Vaccines, Product Types and Applications
Table 12. Global Key Manufacturers of Adult Preventable Vaccines, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Adult Preventable Vaccines Companies by Tier (Tier 1, Tier 2, Tier 3), based on Adult Preventable Vaccines Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Adult Preventable Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Adult Preventable Vaccines Sales by Region (K Dose), 2021–2026
Table 18. Global Adult Preventable Vaccines Sales Market Share by Region (2021–2026)
Table 19. Global Adult Preventable Vaccines Sales by Region (K Dose), 2027–2032
Table 20. Global Adult Preventable Vaccines Sales Market Share by Region (2027–2032)
Table 21. Global Adult Preventable Vaccines Revenue by Region (US$ Million), 2021–2026
Table 22. Global Adult Preventable Vaccines Revenue Market Share by Region (2021–2026)
Table 23. Global Adult Preventable Vaccines Revenue by Region (US$ Million), 2027–2032
Table 24. Global Adult Preventable Vaccines Revenue Market Share by Region (2027–2032)
Table 25. North America Adult Preventable Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Adult Preventable Vaccines Sales by Country (K Dose), 2021–2026
Table 27. North America Adult Preventable Vaccines Sales by Country (K Dose), 2027–2032
Table 28. North America Adult Preventable Vaccines Revenue by Country (US$ Million), 2021–2026
Table 29. North America Adult Preventable Vaccines Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Adult Preventable Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Adult Preventable Vaccines Sales by Country (K Dose), 2021–2026
Table 32. Europe Adult Preventable Vaccines Sales by Country (K Dose), 2027–2032
Table 33. Europe Adult Preventable Vaccines Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Adult Preventable Vaccines Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Adult Preventable Vaccines Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Adult Preventable Vaccines Sales by Region (K Dose), 2021–2026
Table 37. Asia Pacific Adult Preventable Vaccines Sales by Region (K Dose), 2027–2032
Table 38. Asia Pacific Adult Preventable Vaccines Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Adult Preventable Vaccines Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Adult Preventable Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Adult Preventable Vaccines Sales by Country (K Dose), 2021–2026
Table 42. Latin America Adult Preventable Vaccines Sales by Country (K Dose), 2027–2032
Table 43. Latin America Adult Preventable Vaccines Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Adult Preventable Vaccines Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Adult Preventable Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Adult Preventable Vaccines Sales by Country (K Dose), 2021–2026
Table 47. Middle East and Africa Adult Preventable Vaccines Sales by Country (K Dose), 2027–2032
Table 48. Middle East and Africa Adult Preventable Vaccines Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Adult Preventable Vaccines Revenue by Country (US$ Million), 2027–2032
Table 50. Global Adult Preventable Vaccines Sales (K Dose) by Type (2021–2026)
Table 51. Global Adult Preventable Vaccines Sales (K Dose) by Type (2027–2032)
Table 52. Global Adult Preventable Vaccines Sales Market Share by Type (2021–2026)
Table 53. Global Adult Preventable Vaccines Sales Market Share by Type (2027–2032)
Table 54. Global Adult Preventable Vaccines Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Adult Preventable Vaccines Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Adult Preventable Vaccines Revenue Market Share by Type (2021–2026)
Table 57. Global Adult Preventable Vaccines Revenue Market Share by Type (2027–2032)
Table 58. Global Adult Preventable Vaccines Price (US$/Dose) by Type (2021–2026)
Table 59. Global Adult Preventable Vaccines Price (US$/Dose) by Type (2027–2032)
Table 60. Global Adult Preventable Vaccines Sales (K Dose) by Application (2021–2026)
Table 61. Global Adult Preventable Vaccines Sales (K Dose) by Application (2027–2032)
Table 62. Global Adult Preventable Vaccines Sales Market Share by Application (2021–2026)
Table 63. Global Adult Preventable Vaccines Sales Market Share by Application (2027–2032)
Table 64. Global Adult Preventable Vaccines Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Adult Preventable Vaccines Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Adult Preventable Vaccines Revenue Market Share by Application (2021–2026)
Table 67. Global Adult Preventable Vaccines Revenue Market Share by Application (2027–2032)
Table 68. Global Adult Preventable Vaccines Price (US$/Dose) by Application (2021–2026)
Table 69. Global Adult Preventable Vaccines Price (US$/Dose) by Application (2027–2032)
Table 70. Pfizer Inc. Company Information
Table 71. Pfizer Inc. Description and Business Overview
Table 72. Pfizer Inc. Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 73. Pfizer Inc. Adult Preventable Vaccines Product
Table 74. Pfizer Inc. Recent Developments/Updates
Table 75. Merck & Co., Inc. Company Information
Table 76. Merck & Co., Inc. Description and Business Overview
Table 77. Merck & Co., Inc. Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 78. Merck & Co., Inc. Adult Preventable Vaccines Product
Table 79. Merck & Co., Inc. Recent Developments/Updates
Table 80. GlaxoSmithKline plc (GSK) Company Information
Table 81. GlaxoSmithKline plc (GSK) Description and Business Overview
Table 82. GlaxoSmithKline plc (GSK) Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 83. GlaxoSmithKline plc (GSK) Adult Preventable Vaccines Product
Table 84. GlaxoSmithKline plc (GSK) Recent Developments/Updates
Table 85. Sanofi Pasteur Company Information
Table 86. Sanofi Pasteur Description and Business Overview
Table 87. Sanofi Pasteur Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 88. Sanofi Pasteur Adult Preventable Vaccines Product
Table 89. Sanofi Pasteur Recent Developments/Updates
Table 90. Moderna, Inc. Company Information
Table 91. Moderna, Inc. Description and Business Overview
Table 92. Moderna, Inc. Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 93. Moderna, Inc. Adult Preventable Vaccines Product
Table 94. Moderna, Inc. Recent Developments/Updates
Table 95. Serum Institute of India Pvt. Company Information
Table 96. Serum Institute of India Pvt. Description and Business Overview
Table 97. Serum Institute of India Pvt. Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 98. Serum Institute of India Pvt. Adult Preventable Vaccines Product
Table 99. Serum Institute of India Pvt. Recent Developments/Updates
Table 100. Bharat Biotech International Company Information
Table 101. Bharat Biotech International Description and Business Overview
Table 102. Bharat Biotech International Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 103. Bharat Biotech International Adult Preventable Vaccines Product
Table 104. Bharat Biotech International Recent Developments/Updates
Table 105. CSL Limited (Seqirus) Company Information
Table 106. CSL Limited (Seqirus) Description and Business Overview
Table 107. CSL Limited (Seqirus) Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 108. CSL Limited (Seqirus) Adult Preventable Vaccines Product
Table 109. CSL Limited (Seqirus) Recent Developments/Updates
Table 110. Emergent BioSolutions Inc. Company Information
Table 111. Emergent BioSolutions Inc. Description and Business Overview
Table 112. Emergent BioSolutions Inc. Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 113. Emergent BioSolutions Inc. Adult Preventable Vaccines Product
Table 114. Emergent BioSolutions Inc. Recent Developments/Updates
Table 115. Daiichi Sankyo Company Company Information
Table 116. Daiichi Sankyo Company Description and Business Overview
Table 117. Daiichi Sankyo Company Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 118. Daiichi Sankyo Company Adult Preventable Vaccines Product
Table 119. Daiichi Sankyo Company Recent Developments/Updates
Table 120. Novavax, Inc. Company Information
Table 121. Novavax, Inc. Description and Business Overview
Table 122. Novavax, Inc. Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 123. Novavax, Inc. Adult Preventable Vaccines Product
Table 124. Novavax, Inc. Recent Developments/Updates
Table 125. Sinovac Biotech Company Information
Table 126. Sinovac Biotech Description and Business Overview
Table 127. Sinovac Biotech Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 128. Sinovac Biotech Adult Preventable Vaccines Product
Table 129. Sinovac Biotech Recent Developments/Updates
Table 130. Sinopharm Group Co., Company Information
Table 131. Sinopharm Group Co., Description and Business Overview
Table 132. Sinopharm Group Co., Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 133. Sinopharm Group Co., Adult Preventable Vaccines Product
Table 134. Sinopharm Group Co., Recent Developments/Updates
Table 135. Johnson & Johnson (Janssen) Company Information
Table 136. Johnson & Johnson (Janssen) Description and Business Overview
Table 137. Johnson & Johnson (Janssen) Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 138. Johnson & Johnson (Janssen) Adult Preventable Vaccines Product
Table 139. Johnson & Johnson (Janssen) Recent Developments/Updates
Table 140. AstraZeneca plc Company Information
Table 141. AstraZeneca plc Description and Business Overview
Table 142. AstraZeneca plc Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 143. AstraZeneca plc Adult Preventable Vaccines Product
Table 144. AstraZeneca plc Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Adult Preventable Vaccines Distributors List
Table 148. Adult Preventable Vaccines Customers List
Table 149. Adult Preventable Vaccines Market Trends
Table 150. Adult Preventable Vaccines Market Drivers
Table 151. Adult Preventable Vaccines Market Challenges
Table 152. Adult Preventable Vaccines Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Adult Preventable Vaccines
Figure 2. Global Adult Preventable Vaccines Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Adult Preventable Vaccines Market Share by Type: 2025 & 2032
Figure 4. Inactivated Vaccines Product Picture
Figure 5. Subunit Vaccines Product Picture
Figure 6. Mrna Vaccines Product Picture
Figure 7. Viral Vector Vaccines Product Picture
Figure 8. Peptide Vaccines Product Picture
Figure 9. Global Adult Preventable Vaccines Market Value by Application (US$ Million), 2021–2032
Figure 10. Global Adult Preventable Vaccines Market Share by Application: 2025 & 2032
Figure 11. Prevent Influenza
Figure 12. Prevent Pneumococcal Infection
Figure 13. Prevent Hepatitis B
Figure 14. Prevent Herpes Zoster
Figure 15. Prevent Human Papillomavirus (Hpv)
Figure 16. Other
Figure 17. Global Adult Preventable Vaccines Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 18. Global Adult Preventable Vaccines Market Size (US$ Million), 2021–2032
Figure 19. Global Adult Preventable Vaccines Sales (K Dose), 2021–2032
Figure 20. Global Adult Preventable Vaccines Average Price (US$/Dose), 2021–2032
Figure 21. Adult Preventable Vaccines Report Years Considered
Figure 22. Adult Preventable Vaccines Sales Share by Manufacturers in 2025
Figure 23. Global Adult Preventable Vaccines Revenue Share by Manufacturers in 2025
Figure 24. Top 5 and Top 10 Global Adult Preventable Vaccines Players: Market Share by Revenue in Adult Preventable Vaccines in 2025
Figure 25. Adult Preventable Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 26. Global Adult Preventable Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 27. North America Adult Preventable Vaccines Sales Market Share by Country (2021–2032)
Figure 28. North America Adult Preventable Vaccines Revenue Market Share by Country (2021–2032)
Figure 29. United States Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Canada Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Europe Adult Preventable Vaccines Sales Market Share by Country (2021–2032)
Figure 32. Europe Adult Preventable Vaccines Revenue Market Share by Country (2021–2032)
Figure 33. Germany Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. France Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. U.K. Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Italy Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Russia Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Asia Pacific Adult Preventable Vaccines Sales Market Share by Region (2021–2032)
Figure 39. Asia Pacific Adult Preventable Vaccines Revenue Market Share by Region (2021–2032)
Figure 40. China Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Japan Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. South Korea Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. India Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Australia Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. China Taiwan Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Southeast Asia Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Latin America Adult Preventable Vaccines Sales Market Share by Country (2021–2032)
Figure 48. Latin America Adult Preventable Vaccines Revenue Market Share by Country (2021–2032)
Figure 49. Mexico Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Brazil Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Argentina Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Colombia Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Middle East and Africa Adult Preventable Vaccines Sales Market Share by Country (2021–2032)
Figure 54. Middle East and Africa Adult Preventable Vaccines Revenue Market Share by Country (2021–2032)
Figure 55. Turkey Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Saudi Arabia Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. UAE Adult Preventable Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Global Sales Market Share of Adult Preventable Vaccines by Type (2021–2032)
Figure 59. Global Revenue Market Share of Adult Preventable Vaccines by Type (2021–2032)
Figure 60. Global Adult Preventable Vaccines Price (US$/Dose) by Type (2021–2032)
Figure 61. Global Sales Market Share of Adult Preventable Vaccines by Application (2021–2032)
Figure 62. Global Revenue Market Share of Adult Preventable Vaccines by Application (2021–2032)
Figure 63. Global Adult Preventable Vaccines Price (US$/Dose) by Application (2021–2032)
Figure 64. Adult Preventable Vaccines Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Sales Planning Tool Market Research Report 2026
Feb 03, 26
Global Chromium Oxide Powder Market Research Report 2026
Feb 03, 26
Global Shape Memory Actuator Market Research Report 2026
Feb 03, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232